378 related articles for article (PubMed ID: 20169438)
1. The pharmacological treatment of opioid addiction--a clinical perspective.
Lobmaier P; Gossop M; Waal H; Bramness J
Eur J Clin Pharmacol; 2010 Jun; 66(6):537-45. PubMed ID: 20169438
[TBL] [Abstract][Full Text] [Related]
2. Buprenorphine for managing opioid withdrawal.
Gowing L; Ali R; White JM; Mbewe D
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD002025. PubMed ID: 28220474
[TBL] [Abstract][Full Text] [Related]
3. Opioid antagonists with minimal sedation for opioid withdrawal.
Gowing L; Ali R; White JM
Cochrane Database Syst Rev; 2017 May; 5(5):CD002021. PubMed ID: 28553701
[TBL] [Abstract][Full Text] [Related]
4. Opioid dependence.
Praveen KT; Law F; O'Shea J; Melichar J
Am Fam Physician; 2012 Sep; 86(6):565-6. PubMed ID: 23062049
[No Abstract] [Full Text] [Related]
5. Update on pharmacotherapy for treatment of opioid use disorder.
Ayanga D; Shorter D; Kosten TR
Expert Opin Pharmacother; 2016 Dec; 17(17):2307-2318. PubMed ID: 27734745
[TBL] [Abstract][Full Text] [Related]
6. Safety and tolerability of the switch from buprenorphine to buprenorphine/naloxone in an Italian addiction treatment centre.
Stimolo C; Favero VD; Zecchinato G; Buson R; Cusin D; Pellachin P; Simonetto P
Clin Drug Investig; 2010; 30 Suppl 1():27-31. PubMed ID: 20450243
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic switch to buprenorphine/naloxone from buprenorphine alone: clinical experience in an Italian addiction centre.
Montesano F; Zaccone D; Battaglia E; Genco F; Mellace V
Clin Drug Investig; 2010; 30 Suppl 1():13-9. PubMed ID: 20450241
[TBL] [Abstract][Full Text] [Related]
8. Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals.
Law FD; Diaper AM; Melichar JK; Coulton S; Nutt DJ; Myles JS
J Psychopharmacol; 2017 Aug; 31(8):1046-1055. PubMed ID: 28631527
[TBL] [Abstract][Full Text] [Related]
9. Impact of Pharmacological Treatments for Opioid Use Disorder on Mortality.
Kelty E; Hulse G; Joyce D; Preen DB
CNS Drugs; 2020 Jun; 34(6):629-642. PubMed ID: 32215842
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of buprenorphine/naloxone in opioid-dependent patients: an Italian observational study.
Magnelli F; Biondi L; Calabria R; Fiore A; Peluso E; Vonella D; Rota AG
Clin Drug Investig; 2010; 30 Suppl 1():21-6. PubMed ID: 20450242
[TBL] [Abstract][Full Text] [Related]
11. The combination very low-dose naltrexone-clonidine in the management of opioid withdrawal.
Mannelli P; Peindl K; Wu LT; Patkar AA; Gorelick DA
Am J Drug Alcohol Abuse; 2012 May; 38(3):200-5. PubMed ID: 22233189
[TBL] [Abstract][Full Text] [Related]
12. Clinical experience with fortnightly buprenorphine/naloxone versus buprenorphine in Italy: preliminary observational data in an office-based setting.
Amato P
Clin Drug Investig; 2010; 30 Suppl 1():33-9. PubMed ID: 20450244
[TBL] [Abstract][Full Text] [Related]
13. Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice.
Sigmon SC; Bisaga A; Nunes EV; O'Connor PG; Kosten T; Woody G
Am J Drug Alcohol Abuse; 2012 May; 38(3):187-99. PubMed ID: 22404717
[TBL] [Abstract][Full Text] [Related]
14. Opioid dependence treatment: options in pharmacotherapy.
Stotts AL; Dodrill CL; Kosten TR
Expert Opin Pharmacother; 2009 Aug; 10(11):1727-40. PubMed ID: 19538000
[TBL] [Abstract][Full Text] [Related]
15. Adjunctive memantine for opioid use disorder treatment: A systematic review.
Elias AM; Pepin MJ; Brown JN
J Subst Abuse Treat; 2019 Dec; 107():38-43. PubMed ID: 31757263
[TBL] [Abstract][Full Text] [Related]
16. Expanded table: Some drugs for management of opioid withdrawal symptoms.
Med Lett Drugs Ther; 2018 Aug; 60(1554):e144-e146. PubMed ID: 30133422
[No Abstract] [Full Text] [Related]
17. Management of opioid withdrawal symptoms.
Med Lett Drugs Ther; 2018 Aug; 60(1554):137-141. PubMed ID: 30133420
[No Abstract] [Full Text] [Related]
18. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J
Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic treatments for opioid dependence: detoxification and maintenance options.
Kleber HD
Dialogues Clin Neurosci; 2007; 9(4):455-70. PubMed ID: 18286804
[TBL] [Abstract][Full Text] [Related]
20. New directions in the treatment of opioid withdrawal.
Srivastava AB; Mariani JJ; Levin FR
Lancet; 2020 Jun; 395(10241):1938-1948. PubMed ID: 32563380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
